When a stock is up more than 160% in a year, it can be easy to think you missed the boat. However, that's not always the case, and when a high-flying stock like pharma darling Regeneron pulls back, it can serve as a buying opportunity. In the following video, Brenton Flynn explains why investors shouldn't be shocked by the news that has this stock down about 5% today.
If you're an investor looking for big winners like Regeneron, Motley Fool co-founder David Gardner's picks have frequently trounced the market. How? Because he's always on the lookout for revolutionary stocks and recommends them before Wall Street catches on to their disruptive potential. If you're interested in how David discovers his winners, click here to get instant access to a personal tour behind David's Supernova service.
The article Should You Buy the Regeneron Sell-Off? originally appeared on Fool.com.
Brenton Flynn has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.